IPX

Iperionx Ltd

Add to Watchlist

Advanced Chart

56.110

-0.275(-0.488%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

56.750

Open

55.600

VWAP

55.70

Vol

100.52K

Mkt Cap

1.88B

Low

55.0101

Amount

5.60M

EV/EBITDA(TTM)

Total Shares

24.98M

1.81B

EV/OCF(TTM)

P/S(TTM)

IperionX Limited is a titanium metal and critical materials company that uses patented metal technologies to produce high performance titanium alloys, from titanium minerals or scrap titanium, at lower energy and carbon emissions. It is engaged in the exploration and evaluation of its mineral properties in the United States and the research, development, and commercialization of its associated metals technologies to support an integrated titanium processing operation. It holds a 100% interest in the Titan Project, covering more than 11,000 acres of mineral properties in western Tennessee, which it considers prospective for critical minerals including titanium, rare earth elements, silica sand and zircon. Its titanium metal and critical minerals are essential for advanced United States industries including space, aerospace, defense, consumer electronics, hydrogen, electric vehicles and additive manufacturing. It has commissioned hydrogen assisted metallothermic reduction furnace.

1 Analyst Rating

Wall Street analysts forecast IPX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IPX is 64.00 USD with a low forecast of 64.00 USD and a high forecast of 64.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 56.110

Low

64.00

Averages

64.00

High

64.00

Current: 56.110

Low

64.00

Averages

64.00

High

64.00

Roth Capital

Buy

maintain

$64 -> $74

2025-10-01

Reason

Roth Capital

Price Target

$64 -> $74

2025-10-01

maintain

Buy

Reason

Roth Capital raised the firm's price target on IperionX to $74 from $64 and keeps a Buy rating on the shares. The firm cites the company's FY25 results and the receipt of additional government funding as part of its existing $47.1M award, the analyst tells investors in a research note. Roth adds that its higher price target reflects lower future dilution assumptions and a higher multiple on 2029 EBITDA.

Roth Capital

Joe Reagor

Buy

initiated

$64

2025-08-20

Reason

Roth Capital

Joe Reagor

Price Target

$64

2025-08-20

initiated

Buy

Reason

Roth Capital analyst Joe Reagor initiated coverage of IperionX with a Buy rating and $64 price target. The company has a \"game changing\" technology for producing titanium products, the analyst tells investors in a research note. Roth believes IperionX will expand production in the coming years and it sees potential upside to its price target if IperionX can compete in the stainless steel and aluminum markets.

Alliance Global Partners

Jake Sekelsky

Buy

maintain

$32 -> $35

2025-06-06

Reason

Alliance Global Partners

Jake Sekelsky

Price Target

$32 -> $35

2025-06-06

maintain

Buy

Reason

Alliance Global Partners analyst Jake Sekelsky raised the firm's price target on IperionX to $35 from $32 and keeps a Buy rating on the shares. The company recently announced the receipt of a United States Department of Defense contract for up to $99M, which indicates IperionX's status as a near-term commercial supplier of domestic titanium products, the analyst tells investors in a research note. The firm views the award as further validation that the company is on the cusp of commercializing its HAMR titanium processing technology and transitioning to serving as a key player in the on-shoring of the titanium supply chain in the U.S.

B. Riley Securities

Lucas Pipes

Strong Buy

Maintains

$30 → $28

2025-04-22

Reason

B. Riley Securities

Lucas Pipes

Price Target

$30 → $28

2025-04-22

Maintains

Strong Buy

Reason

B. Riley lowered the firm's price target on IperionX to $28 from $30 and keeps a Buy rating on the shares. IperionX is scaling up titanium manufacturing at its Virginia campus, with full operational capacity expected by mid-2025, although Riley now assumes a more conservative ramp, the analyst tells investors in a research note.

B. Riley Securities

Lucas Pipes

Strong Buy

Initiates

$30

2024-10-10

Reason

B. Riley Securities

Lucas Pipes

Price Target

$30

2024-10-10

Initiates

Strong Buy

Reason

B. Riley initiated coverage of IperionX with a Buy rating and $30 price target. The company aims to be a pioneer in the development of low-cost and low-carbon titanium, catering to cutting-edge industries such as space and aerospace engineering, electric vehicles, and 3D printing, the analyst tells investors in a research note. The firm views IperionX as an attractive growth company "that is capturing an important market for titanium production and recycling in the U.S."

See All Ratings

Valuation Metrics

The current forward P/E ratio for Iperionx Ltd (IPX.O) is -1127.70, compared to its 5-year average forward P/E of -52.14. For a more detailed relative valuation and DCF analysis to assess Iperionx Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-52.14

Current PE

-1127.70

Overvalued PE

136.09

Undervalued PE

-240.36

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-18.95

Current EV/EBITDA

-130.06

Overvalued EV/EBITDA

12.47

Undervalued EV/EBITDA

-50.37

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

30.39

Current PS

97.63

Overvalued PS

73.42

Undervalued PS

-12.63